Solara Active Pharma [SOLARAPP] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Solara Active Pharma

BSE

Sequent Scientific

NSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Solara Active Pharma wins in 9 metrics, Sequent Scientific wins in 10 metrics, with 0 ties. Sequent Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Solara Active Pharma	Sequent Scientific	Better
P/E Ratio (TTM)	2,428.57	195.40	Sequent Scientific
Price-to-Book Ratio	1.25	5.96	Solara Active Pharma
Debt-to-Equity Ratio	72.58	62.47	Sequent Scientific
PEG Ratio	-24.26	33.28	Solara Active Pharma
EV/EBITDA	10.57	29.60	Solara Active Pharma
Profit Margin (TTM)	0.04%	1.41%	Sequent Scientific
Operating Margin (TTM)	7.72%	9.41%	Sequent Scientific
EBITDA Margin (TTM)	7.72%	9.41%	Sequent Scientific
Return on Equity	0.05%	4.35%	Sequent Scientific
Return on Assets (TTM)	2.92%	4.01%	Sequent Scientific
Free Cash Flow (TTM)	$1.73B	$442.70M	Solara Active Pharma
1-Year Return	22.59%	22.29%	Solara Active Pharma
Price-to-Sales Ratio (TTM)	1.65	2.71	Solara Active Pharma
Enterprise Value	$21.80B	$46.83B	Sequent Scientific
EV/Revenue Ratio	1.70	3.02	Solara Active Pharma
Gross Profit Margin (TTM)	54.11%	50.28%	Solara Active Pharma
Revenue per Share (TTM)	$333	$62	Solara Active Pharma
Earnings per Share (Diluted)	$0.14	$0.86	Sequent Scientific
Beta (Stock Volatility)	1.12	0.91	Sequent Scientific

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Solara Active Pharma vs Sequent Scientific Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Solara Active Pharma	-0.31%	-3.50%	-4.34%	63.68%	63.53%	4.92%
Sequent Scientific	5.23%	-0.34%	-9.41%	8.30%	7.32%	-9.00%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Solara Active Pharma	22.59%	90.07%	90.07%	90.07%	90.07%	90.07%
Sequent Scientific	22.29%	57.12%	26.68%	13.98%	13.98%	13.98%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Solara Active Pharma (SOLARAPP): View Full Stock Overview

Sequent Scientific (SEQUENT): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Solara Active Pharma vs Sequent Scientific

Metric	SOLARAPP	SEQUENT
Market Information
Market Cap i	₹21.12B	₹42.04B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	578	673,998
90 Day Avg. Volume i	614	526,426
Last Close	₹446.85	₹176.83
52 Week Range	₹215.55 - ₹560.85	₹117.35 - ₹240.70
% from 52W High	-20.33%	-26.54%
All-Time High	₹560.85 (Dec 09, 2024)	₹336.50 (Jun 28, 2021)
% from All-Time High	-20.33%	-47.45%
Growth Metrics
Quarterly Revenue Growth	0.04%	0.11%
Quarterly Earnings Growth	-0.12%	0.12%
Financial Health
Profit Margin (TTM) i	0.00%	0.01%
Operating Margin (TTM) i	0.08%	0.09%
Return on Equity (TTM) i	0.00%	0.04%
Debt to Equity (MRQ) i	72.58	62.47
Cash & Liquidity
Book Value per Share (MRQ)	₹271.86	₹28.19
Cash per Share (MRQ)	₹1.02	₹2.52
Operating Cash Flow (TTM) i	₹2.13B	₹833.62M
Levered Free Cash Flow (TTM) i	₹-173,124,992	₹453.76M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	₹0.00

Valuation & Enterprise Metrics Analysis: Solara Active Pharma vs Sequent Scientific

Metric	SOLARAPP	SEQUENT
Price Ratios
P/E Ratio (TTM) i	2,428.57	195.40
Forward P/E i	N/A	33.28
PEG Ratio i	-24.26	33.28
Price to Sales (TTM) i	1.65	2.71
Price to Book (MRQ) i	1.25	5.96
Market Capitalization
Market Capitalization i	₹21.12B	₹42.04B
Enterprise Value i	₹21.80B	₹46.83B
Enterprise Value Metrics
Enterprise to Revenue i	1.70	3.02
Enterprise to EBITDA i	10.57	29.60
Risk & Other Metrics
Beta i	1.12	0.91
Book Value per Share (MRQ) i	₹271.86	₹28.19

Financial Statements Comparison: Solara Active Pharma vs Sequent Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SOLARAPP	SEQUENT
Revenue/Sales i	₹3.19B	₹4.02B
Cost of Goods Sold i	₹1.46B	₹2.00B
Gross Profit i	₹1.73B	₹2.02B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹334.40M	₹294.80M
EBITDA i	₹580.00M	₹442.10M
Pre-Tax Income i	₹105.20M	₹163.10M
Income Tax i	₹0	₹59.30M
Net Income (Profit) i	₹105.20M	₹103.80M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SOLARAPP	SEQUENT
Cash & Equivalents i	₹39.50M	₹626.60M
Total Current Assets i	₹7.29B	₹8.74B
Total Current Liabilities i	₹9.44B	₹5.05B
Long-Term Debt i	₹1.32B	₹3.00B
Total Shareholders Equity i	₹10.97B	₹7.70B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹7.96B	₹2.84B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SOLARAPP	SEQUENT
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SOLARAPP	SEQUENT
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	578	673,998
Average Daily Volume (90 Day) i	614	526,426
Shares Outstanding i	48.05M	249.89M
Float Shares i	27.66M	117.77M
% Held by Insiders i	0.00%	0.53%
% Held by Institutions i	0.04%	0.13%

Dividend Analysis & Yield Comparison: Solara Active Pharma vs Sequent Scientific

Metric	SOLARAPP	SEQUENT
Last 12-Month Dividend i	N/A	₹0.00
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	₹0.00
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	₹0.00
Ex-Dividend Date	N/A	N/A

Solara Active Pharma [SOLARAPP] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison